IT8424009A1 - Composizioni analgesiche ed anti-infiammatorie migliorate, comprendenti xantine e metodi di utilizzare le stesse - Google Patents

Composizioni analgesiche ed anti-infiammatorie migliorate, comprendenti xantine e metodi di utilizzare le stesse

Info

Publication number
IT8424009A1
IT8424009A1 IT1984A24009A IT2400984A IT8424009A1 IT 8424009 A1 IT8424009 A1 IT 8424009A1 IT 1984A24009 A IT1984A24009 A IT 1984A24009A IT 2400984 A IT2400984 A IT 2400984A IT 8424009 A1 IT8424009 A1 IT 8424009A1
Authority
IT
Italy
Prior art keywords
xanthines
methods
inflammatory compositions
improved analgesic
analgesic
Prior art date
Application number
IT1984A24009A
Other languages
English (en)
Other versions
IT1177389B (it
IT8424009A0 (it
Original Assignee
Richardson Vicks Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Incorporated filed Critical Richardson Vicks Incorporated
Publication of IT8424009A0 publication Critical patent/IT8424009A0/it
Publication of IT8424009A1 publication Critical patent/IT8424009A1/it
Application granted granted Critical
Publication of IT1177389B publication Critical patent/IT1177389B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT24009/84A 1983-12-12 1984-12-12 Composizioni analgesiche ed anti-infiammatorie migliorate, comprendente xantine e metodi di utilizzare le stesse IT1177389B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/560,576 US4558051A (en) 1983-10-11 1983-12-12 Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Publications (3)

Publication Number Publication Date
IT8424009A0 IT8424009A0 (it) 1984-12-12
IT8424009A1 true IT8424009A1 (it) 1986-06-12
IT1177389B IT1177389B (it) 1987-08-26

Family

ID=24238396

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24009/84A IT1177389B (it) 1983-12-12 1984-12-12 Composizioni analgesiche ed anti-infiammatorie migliorate, comprendente xantine e metodi di utilizzare le stesse

Country Status (15)

Country Link
US (1) US4558051A (it)
EP (1) EP0165308B1 (it)
JP (1) JPS61500665A (it)
AT (1) AT389997B (it)
AU (1) AU574419B2 (it)
CA (1) CA1246453A (it)
CH (1) CH669730A5 (it)
DE (1) DE3490583T1 (it)
GB (1) GB2161076B (it)
IE (1) IE58158B1 (it)
IT (1) IT1177389B (it)
NL (1) NL8420316A (it)
SE (1) SE469874B (it)
WO (1) WO1985002540A1 (it)
ZA (1) ZA849675B (it)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
HU197746B (en) * 1985-09-05 1989-05-29 Sandoz Ag Process for producing xantin derivatives and pharmaceutical compositions containing them
CH669523A5 (it) * 1986-06-25 1989-03-31 Mepha Ag
DE3779374D1 (en) * 1986-08-28 1992-07-02 Sandoz Ag Xanthinderivate.
CH670090A5 (it) * 1986-10-27 1989-05-12 Nestle Sa
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
EP0317206B1 (en) * 1987-11-13 1993-04-28 Glaxo Group Limited Phenethanolamine derivatives
US4883818A (en) * 1987-11-17 1989-11-28 Analgesic Associates Onset-hastened/enhanced analgesia
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
WO1992004021A1 (en) * 1990-09-11 1992-03-19 Richardson Vicks Inc. Method for providing improved analgesic effect
JPH08501796A (ja) * 1992-09-29 1996-02-27 メルク エンド カンパニー インコーポレーテッド イブプロフェン−カフェイン配合物
US5340813A (en) * 1992-11-09 1994-08-23 Cell Therapeutics, Inc. Substituted aminoalkyl xanthine compounds
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6586429B2 (en) * 2000-11-29 2003-07-01 Cell Therapeutics, Inc. Tricyclic fused xanthine compounds and their uses
KR20030048026A (ko) 2001-07-06 2003-06-18 펜웨스트 파머슈티칼즈 컴파니 옥시모르폰의 서방형 제제
WO2003004031A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US7317017B2 (en) * 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
EP1444233B1 (en) 2001-11-09 2011-08-17 Gilead Palo Alto, Inc. A2b adenosine receptor antagonists
US6977300B2 (en) * 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
JP4929173B2 (ja) * 2004-09-01 2012-05-09 ギリアード・パロ・アルト・インコーポレイテッド Ａ２ｂアデノシンレセプターアンタゴニストを使用する創傷治癒の方法
CL2007002425A1 (es) * 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
ES2828574T3 (es) 2015-04-08 2021-05-26 Lewis And Clark Pharmaceuticals Inc Carbamatos de alquinilo sustituidos con xantina/carbamatos inversos como antagonistas de A2B
CN109912598B (zh) * 2019-03-27 2022-09-13 四川大学华西医院 防治炎症反应的核苷类衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US3936528A (en) * 1974-02-13 1976-02-03 Syntex Corporation Analgesic formulations having enhanced therapeutic activity
AU532600B2 (en) * 1977-04-02 1983-10-06 Hoechst A.G. Alkenyl xanthines and pharmaceutical compositions
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
WO1984000488A1 (en) * 1982-07-22 1984-02-16 Richardson Vicks Inc Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4479956A (en) * 1983-04-26 1984-10-30 Analgeic Associates Analgesic compositions comprising propiram and methods of using same

Also Published As

Publication number Publication date
EP0165308A1 (en) 1985-12-27
GB2161076A (en) 1986-01-08
SE8503762L (sv) 1985-08-09
EP0165308A4 (en) 1986-05-16
IE843166L (en) 1985-06-12
NL8420316A (nl) 1985-11-01
CA1246453A (en) 1988-12-13
ATA905384A (de) 1989-08-15
AT389997B (de) 1990-02-26
WO1985002540A1 (en) 1985-06-20
AU574419B2 (en) 1988-07-07
GB2161076B (en) 1988-03-30
US4558051A (en) 1985-12-10
EP0165308B1 (en) 1989-03-22
IT1177389B (it) 1987-08-26
CH669730A5 (it) 1989-04-14
JPS61500665A (ja) 1986-04-10
IE58158B1 (en) 1993-07-28
DE3490583T1 (de) 1986-04-03
SE8503762D0 (sv) 1985-08-09
AU3747485A (en) 1985-06-26
SE469874B (sv) 1993-10-04
IT8424009A0 (it) 1984-12-12
GB8519256D0 (en) 1985-09-04
ZA849675B (en) 1985-07-31

Similar Documents

Publication Publication Date Title
IT8424009A1 (it) Composizioni analgesiche ed anti-infiammatorie migliorate, comprendenti xantine e metodi di utilizzare le stesse
IT8519382A0 (it) Composizioni analgesiche e antiinfiammatorie comprendenti difeni dramina e metodi di usare le stesse
EP0167566A4 (en) ANALGESIC AND ANTI-IGNITION COMPOSITIONS CONTAINING XANTHINE AND METHOD FOR THE USE THEREOF.
IT1177375B (it) Composizione e procedimento per inibire le incrostazioni
ES536469A0 (es) Procedimiento para preparar nuevas 1-bencil-aminoalquil-pirrolidinonas
DK264785A (da) Galenisk retardpraeparat
MC1628A1 (fr) Nouvelles triazines et leur preparation
IT1167123B (it) Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono
IT1186761B (it) Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti
ES544116A0 (es) Procedimiento para preparar nuevos bencimidazoles
FI840138A0 (fi) Detergentblandning i partikelform
ES548236A0 (es) Procedimiento para preparar adenosinas n6 sustituidas
IT1163931B (it) Composizione e metodo per impedire la formazione di incrostazioni
IT1227456B (it) Nuovi alcossi derivati di ginkgolidi, loro preparazione e composizioni terapeutiche che li contengono
ES548235A0 (es) Procedimiento para preparar n6-benzopirano- y benzotiopira- no-adenosinas
IT8548964A0 (it) 8alfa-acilamminoergoline,loro preparazione e composizioni farmaceutiche che le contengono
DK41585A (da) Udtrykkelse af human alfa-1-antitrypsin i gaer
IT1170361B (it) Cianoguanidine, procedimento per ottenerle e composizioni farmaceutiche che le contengono
IT8547703A0 (it) Composizioni farmaceutiche comprendenti la bromocriptina
TR22560A (tr) Sulfonilguanidinopirimidin tuerevleri
IT1177658B (it) Procedimento per preparare ed applicare derivati di pirimidintrione
ES531586A0 (es) Procedimiento para preparar difenilazometinas
IT1200472B (it) Derivati chinolinici,loro preparazione e composizioni terapeutiche che li contengono
IT1178790B (it) Procedimento di preparazione di miscele carbone-acqua
FR2549054B1 (fr) 1-phenoxy-3-hydroxyindolylalkylamino-2-propanols, leur preparation et leur application pharmacologique

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19981231